Cullen/Frost Bankers, Inc. Adma Biologics, Inc. Transaction History
Cullen/Frost Bankers, Inc.
- $7.21 Billion
- Q4 2024
A detailed history of Cullen/Frost Bankers, Inc. transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Cullen/Frost Bankers, Inc. holds 827 shares of ADMA stock, worth $12,950. This represents 0.0% of its overall portfolio holdings.
Number of Shares
827
Previous 801
3.25%
Holding current value
$12,950
Previous $16,000
12.5%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ADMA
# of Institutions
329Shares Held
192MCall Options Held
917KPut Options Held
91.6K-
Black Rock Inc. New York, NY18.6MShares$292 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$285 Million0.01% of portfolio
-
State Street Corp Boston, MA13MShares$204 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA12.6MShares$198 Million0.05% of portfolio
-
Morgan Stanley New York, NY8.6MShares$135 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.07B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...